For the Media
Dr. Peter Nelson is a member of Fred Hutch's Human Biology Division. He is an oncologist specialiszing in therapiesfor prostate cancer. His research focuses on understanding the molecular, cellular and physiological events that lead to cancer initiation and progression. Dr. Nelson's work studies the genomic features of prostate cancer tumors with the goal of developing diagnostic, prognostic, and therapeutic strategies.
Overview of Peter Nelson's Research
Dr. Nelson's research explores gene expression variability, the role of the androgen receptor pathway and the tumor microenvironment and their role in the response and resistance mechanisms to prostate cancer therapies.
Peter Nelson - Brief Curriculum Vitae
Appointments, affiliations and researcher interests
Peter Nelson Lab
The Peter Nelson Lab investigators are working to uncover how prostate cancer forms. Our goal is to create tools to diagnose the onset of prostate cancer, and also help develop more effective therapies for treating this disease.
Human Biology Division
Human Biology researchers come together to form a multidisciplinary team that is influenced by individual advances. Their diverse expertise include molecular and cell biology, genomics, genetics, virology, infectious disease, computational biology, pathology and clinical research.
Mpower Prostate Cancer Registry
A partnership between Fred Hutch, the Washington State Prostate Cancer Coalition and urologists across Washington state, and eventually the entire Northwest region, who are interested in improving how we treat prostate cancer patients.
At Fred Hutchinson Cancer Research Center, home to three Nobel laureates, interdisciplinary teams of world-renowned scientists seek new and innovative ways to prevent, diagnose and treat cancer, HIV/AIDS and other life-threatening diseases. Fred Hutch’s pioneering work in bone marrow transplantation led to the development of immunotherapy, which harnesses the power of the immune system to treat cancer. An independent, nonprofit research institute based in Seattle, Fred Hutch houses the nation’s first National Cancer Institute-funded cancer prevention research program, as well as the clinical coordinating center of the Women’s Health Initiative and the international headquarters of the HIV Vaccine Trials Network.